# Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

> **NCT06326086** · — · UNKNOWN · sponsor: **Prince of Songkla University** · enrollment: 240 (estimated)

## Conditions studied

- Advanced Lung Cancer
- Sarcopenia

## Interventions

- **DRUG:** Chemotherapy drug
- **DRUG:** Targeted Agent
- **DRUG:** Immunotherapy

## Key facts

- **NCT ID:** NCT06326086
- **Lead sponsor:** Prince of Songkla University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-01
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06326086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06326086, "Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06326086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*